AAMU
RMD icon

Amundi Asset Management US’s ResMed RMD Stock Holding History

Amundi Asset Management US’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$148M Buy
761,704
+147,073
+24% +$29.5M 0.11% 198
2020
Q4 		$131M Sell
614,631
-2,996
-0.5% -$597K 0.11% 202
2020
Q3 		$106M Buy
617,627
+66,966
+12% +$12.4M 0.11% 191
2020
Q2 		$106M Buy
550,661
+349,282
+173% +$57.1M 0.13% 170
2020
Q1 		$29.5M Sell
201,379
-11,960
-6% -$1.9M 0.05% 310
2019
Q4 		$33.1M Sell
213,339
-58,841
-22% -$8.48M 0.04% 408
2019
Q3 		$36.8M Sell
272,180
-501,664
-65% -$65.7M 0.05% 352
2019
Q2 		$94.4M Buy
773,844
+310,273
+67% +$34.4M 0.08% 197
2019
Q1 		$48.2M Buy
463,571
+253,153
+120% +$26.1M 0.07% 291
2018
Q4 		$24K Buy
210,418
+47,661
+29% +$5.11M 0.02% 422
2018
Q3 		$18.8M Sell
162,757
-19,413
-11% -$2.13M 0.02% 554
2018
Q2 		$18.9M Buy
182,170
+88,322
+94% +$8.94M 0.03% 537
2018
Q1 		$9.24M Buy
93,848
+7,807
+9% +$738K 0.01% 696
2017
Q4 		$7.29M Buy
+86,041
New +$7.11M 0.01% 760

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Amundi Asset Management US's RMD Position: Q1 2021 in Review

Amundi Asset Management US increased its ResMed (RMD) stake by 24% in Q1 2021, buying an estimated $29.5M and bringing the position to 761,704 shares worth $148M. The position accounts for 0.11% of the portfolio, ranked #198.

Amundi Asset Management US first reported a position in RMD in Q4 2017 and has held it in 14 quarters since. 662 funds tracked by Wall St. Rank hold RMD as of Q1 2021.

  • Amundi Asset Management US held 761,704 shares of ResMed worth $148M as of Q1 2021.
  • Amundi Asset Management US bought 147,073 ResMed shares in Q1 2021, an estimated $29.5M.
  • ResMed made up 0.11% of Amundi Asset Management US's portfolio in Q1 2021, its #198 holding.
  • Amundi Asset Management US first reported a position in ResMed in Q4 2017 and has held it in 14 quarters since.
  • 662 funds tracked by Wall St. Rank held ResMed as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.